Cross-Sectional Survey on the Use of Tobacco Products - London (UK)

Last updated: February 26, 2024
Sponsor: Philip Morris Products S.A.
Overall Status: Terminated

Phase

N/A

Condition

N/A

Treatment

Survey on Use of Tobacco Products in the General Population

Survey on Use of Tobacco Products in IQOS Users

Clinical Study ID

NCT03527030
P1-PMX-04-UK
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in London, United Kingdom.

The study was prematurely terminated after the first annual survey and was not be repeated due to the impossibility to recruit sufficient participants to meet the target sample size in the IQOS user sample.

Eligibility Criteria

Inclusion

Inclusion Criteria (all participants, including IQOS users):

  • Legally permitted to buy tobacco products in UK (≥18 years of age).
  • Currently residing in the Greater London area.
  • Able to read, write and understand English.
  • Consent to participate in the survey Inclusion Criteria (IQOS users only):
  • Has used more than 100 HEETS tobacco sticks in his or her lifetime.
  • Is currently using IQOS.
  • Has access to the internet.
  • Is not currently employed by Philip Morris International or any of its affiliates

Exclusion

Exclusion Criteria:

  • Not meeting the inclusion criteria

Study Design

Total Participants: 6116
Treatment Group(s): 2
Primary Treatment: Survey on Use of Tobacco Products in the General Population
Phase:
Study Start date:
March 08, 2018
Estimated Completion Date:
June 14, 2019

Study Description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of the Greater London area and in adult IQOS users registered in the IQOS user database of Philip Morris Limited (UK IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are:

  1. Estimate the prevalence of current tobacco use status in the study population.

  2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse).

  3. Explore the association between self-reported health status and use of tobacco products in the study population.

  4. Explore the association between patterns of IQOS use including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in the Greater London area registered in UK IQOS User Database.

Connect with a study center

  • Philip Morris Products S.A.

    Lausanne, Vaud 1007
    Switzerland

    Site Not Available

  • Philip Morris Products S.A.

    Neuchatel, 2000
    Switzerland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.